Guided Therapeutics (GTHP) Other Gross PP&E Adjustments (2014 - 2025)

Guided Therapeutics recorded quarterly Other Gross PP&E Adjustments of -$686000.0 in Q4 2025, down 894.2% quarter-over-quarter from -$69000.0 in Q3 2025, and down 386.52% year-over-year from $239420.8 in Q4 2024.

Guided Therapeutics' Other Gross PP&E Adjustments history runs 9 years deep, the most recent figure standing at -$686000.0 for Q4 2025.

  • In Q4 2025, Other Gross PP&E Adjustments fell 386.52% year-over-year to -$686000.0; the TTM figure through Dec 2025 stood at -$686000.0 (down 386.52% YoY), while the FY2025 annual figure was -$686000.0, down 386.52% from the prior year.
  • Other Gross PP&E Adjustments came in at -$686000.0 for Q4 2025 at Guided Therapeutics, down from -$69000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$69000.0 in Q3 2025 to a low of -$686000.0 in Q4 2025.
  • A 5-year average of -$300500.0 and a median of -$303000.0 in 2022 frame the typical range for Other Gross PP&E Adjustments.
  • Across the five-year window, Other Gross PP&E Adjustments slumped 536.07% in 2021 and soared 69.61% in 2024, its largest moves.
  • Guided Therapeutics' Other Gross PP&E Adjustments stood at -$372000.0 in 2021, then slipped by 29.3% to -$481000.0 in 2022, then rose by 3.53% to -$464000.0 in 2023, then jumped by 69.61% to -$141000.0 in 2024, then slumped by 386.52% to -$686000.0 in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$686000.0, -$69000.0, and -$94000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 23.14 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -405.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -547.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -99.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.55 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.39 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 991.00 Mn
10 Guided Therapeutics - - 458,000.00 -686,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -686,000.00
Dec 31, 2025 -686,000.00
Sep 30, 2025 -69,000.00
Sep 30, 2025 -69,000.00
Jun 30, 2025 -94,000.00
Jun 30, 2025 -94,000.00
Mar 31, 2025 -118,000.00
Mar 31, 2025 -118,000.00
Dec 31, 2024 -141,000.00
Dec 31, 2024 -141,000.00
Sep 30, 2024 -164,000.00
Sep 30, 2024 -164,000.00
Jun 30, 2024 -185,000.00
Jun 30, 2024 -185,000.00
Mar 31, 2024 -207,000.00
Mar 31, 2024 -207,000.00
Dec 31, 2023 -464,000.00
Dec 31, 2023 -464,000.00
Sep 30, 2023 -247,000.00
Sep 30, 2023 -247,000.00
Jun 30, 2023 -266,000.00
Jun 30, 2023 -266,000.00
Mar 31, 2023 -285,000.00
Mar 31, 2023 -285,000.00
Dec 31, 2022 -481,000.00
Dec 31, 2022 -481,000.00
Sep 30, 2022 -321,000.00
Sep 30, 2022 -321,000.00
Jun 30, 2022 -338,000.00
Jun 30, 2022 -338,000.00
Mar 31, 2022 -355,000.00
Mar 31, 2022 -355,000.00
Dec 31, 2021 -372,000.00
Dec 31, 2021 -372,000.00
Sep 30, 2021 -388,000.00
Sep 30, 2021 -388,000.00
Jun 30, 2021 -403,000.00
Jun 30, 2021 -403,000.00
Mar 31, 2021 -426,000.00
Mar 31, 2021 -426,000.00
Dec 31, 2020 1.29 Mn
Dec 31, 2020 1.29 Mn
Sep 30, 2020 -61,000.00
Sep 30, 2020 -61,000.00
Jun 30, 2020 -86,000.00
Jun 30, 2020 -86,000.00
Mar 31, 2020 -109,000.00
Mar 31, 2020 -109,000.00
Dec 31, 2019 2.26 Mn
Dec 31, 2019 2.26 Mn
Sep 30, 2019 -153,000.00
Sep 30, 2019 -153,000.00
Jun 30, 2019 -175,000.00
Jun 30, 2019 -175,000.00
Mar 31, 2019 -202,000.00
Mar 31, 2019 -202,000.00
Jun 30, 2015 -1.39 Mn
Jun 30, 2015 -1.39 Mn
Dec 31, 2014 -1.39 Mn
Dec 31, 2014 -1.39 Mn